© Reuters. FILE PHOTO: Empty vials of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are seen at The Michener Institute, in Toronto, Canada January 4, 2021. REUTERS/Carlos Osorio
TORONTO (Reuters) -Canada is authorizing the use of Pfizer Inc (NYSE:)’s COVID-19 vaccine for use in children from 12 to 15, the first dose to be allowed for people that young, the federal health ministry said on Wednesday.
“The department determined that this vaccine is safe and effective when used in this younger age group,” Supriya Sharma, a senior adviser at the ministry, told a briefing. “We are starting to see the light at the end of the tunnel.”
Canada’s federal government has bought tens of millions of doses of vaccines but critics complain the pace of inoculation is lagging amid bottlenecks in the 10 provinces, which are responsible for administering the doses.
Sharma said Pfizer, which is working with German partner BioNTech SE (NASDAQ:), would be required to provide information on the safety, efficacy and quality of the vaccine in the 12 to 15 age group.
Around 20% of the 1,249,950 cases of COVID-19 in Canada have been reported in people under the age of 19. Canada has also recorded 24,396 deaths.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Need Your Help Today. Your $1 can change life.